Medibio Ltd (MEB)

Sydney
0.002
0.000(0.00%)
  • Volume:
    25,846,642
  • Bid/Ask:
    0.001/0.002
  • Day's Range:
    0.001 - 0.002

MEB Overview

Prev. Close
0.002
Day's Range
0.001-0.002
Revenue
1.22M
Open
0.001
52 wk Range
0.001-0.013
EPS
0
Volume
25,846,642
Market Cap
4.79M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,857,010
P/E Ratio
-
Beta
1.92
1-Year Change
-71.43%
Shares Outstanding
2,396,990,123
Next Earnings Date
-
What is your sentiment on Medibio Ltd?
or
Vote to see community's results!

Medibio Ltd Company Profile

Medibio Ltd Company Profile

Employees
0
Market
Australia

Medibio Limited is Australia-based health technology company. The Company offers mental well-being solutions for businesses and are also developing products to serve the healthcare provider market. It offers a software called MEBsleep, a medical device that analyses Electroencephalogram (EEG) and Electrocardiogram (ECG) data collected during polysomnography to verify sleep stages and heart rate variability (HRV) in patients suffering from primary or secondary sleep disturbances. The Company’s subsidiaries include Bioprospect Australia Pty Ltd, Australian Phytochemicals Pty Ltd, BioProspect America Pty Ltd, Medibio Limited USA, Invatec Health Pty Ltd and Annapanna Pty Ltd.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellStrong Sell
Technical IndicatorsNeutralNeutralSellStrong SellStrong Sell
SummaryNeutralNeutralSellStrong SellStrong Sell